Costly new breast cancer therapies augment the significant burden this disease places on healthcare resources, but in context they may still provide value to society.
Osman I. Ahmed, MD, DrPH
Advertisement
Articles by Osman I. Ahmed, MD, DrPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
3
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
4
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
5